Literature DB >> 18207062

The relationship between the antiphospholipid syndrome and heparin-induced thrombocytopenia.

Debra A Hoppensteadt1, Jeanine M Walenga.   

Abstract

Antiphospholipid syndrome (APS) and heparin-induced thrombocytopenia (HIT) are immune-mediated thrombotic conditions caused by antibodies targeted to a protein-antigen complex. Although each disorder is attributed to two distinct antibodies, these autoimmune disorders are characterized by a similar pathogenesis that includes a hypercoagulable state, platelet activation, damage to the vascular endothelium, and inflammation. APS and HIT share similarities in the clinical presentation because each is associated with thrombocytopenia, a high risk of thrombosis in all venous and arterial sites, and catastrophic thrombotic outcomes occur if untreated. Understanding the disease process for one disorder could potentially aid in understanding the other disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18207062     DOI: 10.1016/j.hoc.2007.11.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  5 in total

Review 1.  The significance and management of thrombocytopenia in antiphospholipid syndrome.

Authors:  Bahar Artim-Esen; Reyhan Diz-Küçükkaya; Murat İnanç
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

2.  Coexistence of Antiphospholipid Syndrome and Heparin-Induced Thrombocytopenia in a Patient with Recurrent Venous Thromboembolism.

Authors:  Samuel Adediran; Nicole Agostino
Journal:  Case Rep Hematol       Date:  2017-04-26

3.  Pulmonary Endarterectomy in Patients with Antiphospholipid Syndrome-Associated Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Serpil Taş; Arzu Antal; Ali Fuad Durusoy; Mehmed Yanartaş; Kübra Yıldız; Şehnaz Olgun Yıldızeli; Derya Kocakaya; Bülent Mutlu; Fatma Alibaz-Öner; Haner Direskeneli; Nevsun İnanç; Atakan Erkılınç; Bedrettin Yıldızeli
Journal:  Anatol J Cardiol       Date:  2022-05       Impact factor: 1.475

4.  Thrombocytopenia in the first trimester predicts adverse pregnancy outcomes in obstetric antiphospholipid syndrome.

Authors:  Jiayang Jin; Xue Xu; Lei Hou; Yuke Hou; Jing Li; Meiying Liang; Chun Li
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

Review 5.  Advances in the Research on Anticardiolipin Antibody.

Authors:  Dan Wang; Wenxin Lv; Shichang Zhang; Jiexin Zhang
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.